Adjusting the labeling conditions to ensure similar fluorophore amounts on all three CD276 antibodies, we injected 50 μg (~2 mg/kg) of each antibody-fluorophore conjugate (AFC) into tumor-bearing mice and performed fluorescence imaging in vivo and ex vivo after 72 h. This evidence concerns the gene CD276 and neoplasm.